Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant Bacteria

News   Nov 23, 2017 | Original story from Aarhus University

 
Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant Bacteria
 
 
 

RELATED ARTICLES

Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”

News

Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.

Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.

READ MORE

Understanding the Process of Cell Division

News

Using multiple techniques such as structural modelling, X-ray scattering, X-ray crystallography and electron microscopy, scientists have found that the Spc110 protein provides a greater function in mitosis originally believed. This information could help understand the process in human cells and the abnormalities that occur in cancer.

READ MORE

Researchers Test Drug Transfer Using Placenta-On-A-Chip

News

Researchers have demonstrated the feasibility of their "organ-on-a-chip" platform in studying how drugs are transported across the human placental barrier.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cell Science Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE